156 related articles for article (PubMed ID: 31970496)
1. Systemic sclerosis in mother and daughter with susceptible HLA haplotype and anti-topoisomerase I autoantibodies.
Kurteva EK; Boyadzhieva VV; Stoilov NR
Rheumatol Int; 2020 Jun; 40(6):1001-1009. PubMed ID: 31970496
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.
Arnett FC; Gourh P; Shete S; Ahn CW; Honey RE; Agarwal SK; Tan FK; McNearney T; Fischbach M; Fritzler MJ; Mayes MD; Reveille JD
Ann Rheum Dis; 2010 May; 69(5):822-7. PubMed ID: 19596691
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA-DRB1*15:02:01, DQB1*05:01:24 and DPB1*13:01:01 in Thai patients with systemic sclerosis.
Louthrenoo W; Kasitanon N; Wongthanee A; Okudaira Y; Takeuchi M; Nakajima F; Habata M; Masuya A; Noguchi H; Inoko H; Takeuchi F
HLA; 2022 Dec; 100(6):563-581. PubMed ID: 36054790
[TBL] [Abstract][Full Text] [Related]
4. HLA-DQB1 associations with anti-topoisomerase-1 antibodies in patients with systemic sclerosis and their first degree relatives. United Kingdom Systemic Sclerosis Study Group.
Whyte J; Artlett C; Harvey G; Stephens CO; Welsh K; Black C; Maddison PJ; McHugh NJ
J Autoimmun; 1994 Aug; 7(4):509-20. PubMed ID: 7980852
[TBL] [Abstract][Full Text] [Related]
5. Comparing HLA shared epitopes in French Caucasian patients with scleroderma.
Azzouz DF; Rak JM; Fajardy I; Allanore Y; Tiev KP; Farge-Bancel D; Martin M; Kanaan SB; Pagni PP; Hachulla E; Harlé JR; Didelot R; Granel B; Cabane J; Roudier J; Lambert NC
PLoS One; 2012; 7(5):e36870. PubMed ID: 22615829
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen (HLA)-DRB1 allele polymorphisms and systemic sclerosis.
Xu Y; Mo N; Jiang Z; Lu S; Fu S; Wei X; Zhao D; Xie Z; Jia W; Liu J; Wang X; Shi D; Jiao Y; Liu C; Yang X
Mod Rheumatol; 2019 Nov; 29(6):984-991. PubMed ID: 30175673
[No Abstract] [Full Text] [Related]
7. Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.
Stevens AM; Kanaan SB; Torok KS; Medsger TA; Mayes MD; Reveille JD; Klein-Gitelman M; Reed AM; Lee T; Li SC; Henstorf G; Luu C; Aydelotte T; Nelson JL
Arthritis Rheumatol; 2016 Nov; 68(11):2772-2777. PubMed ID: 27214100
[TBL] [Abstract][Full Text] [Related]
8. Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies.
Liem SIE; Neppelenbroek S; Fehres CM; Wevers BA; Toes REM; Allaart CF; Huizinga TWJ; Scherer HU; De Vries-Bouwstra JK
RMD Open; 2023 Feb; 9(1):. PubMed ID: 36746531
[TBL] [Abstract][Full Text] [Related]
9. [High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis].
Dol C; Granel B; Resseguier N; Kaplanski G; Reynaud-Gaubert M; Schleinitz N; Grob JJ; Delaporte E; Lafforgue P; Rossi P; Bardin N; Benyamine A
Rev Med Interne; 2024 Mar; 45(3):126-131. PubMed ID: 38355359
[TBL] [Abstract][Full Text] [Related]
10. Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.
Furukawa H; Oka S; Kawasaki A; Shimada K; Sugii S; Matsushita T; Hashimoto A; Komiya A; Fukui N; Kobayashi K; Osada A; Ihata A; Kondo Y; Nagai T; Setoguchi K; Okamoto A; Okamoto A; Chiba N; Suematsu E; Kono H; Katayama M; Hirohata S; Sumida T; Migita K; Hasegawa M; Fujimoto M; Sato S; Nagaoka S; Takehara K; Tohma S; Tsuchiya N
PLoS One; 2016; 11(4):e0154255. PubMed ID: 27116456
[TBL] [Abstract][Full Text] [Related]
11. Association of the HLA-DRB1 with scleroderma in Chinese population.
He D; Wang J; Yi L; Guo X; Guo S; Guo G; Tu W; Wu W; Yang L; Xiao R; Li Y; Chu H; Lai S; Jin L; Zou H; Reveille JD; Assassi S; Mayes MD; Zhou X
PLoS One; 2014; 9(9):e106939. PubMed ID: 25184637
[TBL] [Abstract][Full Text] [Related]
12. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
[TBL] [Abstract][Full Text] [Related]
13. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
[TBL] [Abstract][Full Text] [Related]
14. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis.
Beretta L; Rueda B; Marchini M; Santaniello A; Simeón CP; Fonollosa V; Caronni M; Rios-Fernandez R; Carreira P; Rodriguez-Rodriguez L; ; Moreno A; López-Nevot MA; Escalera A; González-Escribano MF; Martin J; Scorza R
Rheumatology (Oxford); 2012 Jan; 51(1):52-9. PubMed ID: 22087014
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.
Acosta-Herrera M; Kerick M; Lopéz-Isac E; Assassi S; Beretta L; Simeón-Aznar CP; Ortego-Centeno N; ; Proudman SM; ; Hunzelmann N; Moroncini G; de Vries-Bouwstra JK; Orozco G; Barton A; Herrick AL; Terao C; Allanore Y; Brown MA; Radstake TR; Fonseca C; Denton CP; Mayes MD; Martin J
Ann Rheum Dis; 2021 Aug; 80(8):1040-1047. PubMed ID: 34096881
[TBL] [Abstract][Full Text] [Related]
17. HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients.
Fanning GC; Welsh KI; Bunn C; Du Bois R; Black CM
Br J Rheumatol; 1998 Feb; 37(2):201-7. PubMed ID: 9569077
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen association in systemic sclerosis patients: our experience at a tertiary care center in North India.
Machhua S; Sharma SK; Kumar Y; Singh S; Aggarwal R; Anand S; Kumar M; Singh H; Minz RW
Front Immunol; 2023; 14():1179514. PubMed ID: 37781395
[TBL] [Abstract][Full Text] [Related]
19.
Gourh P; Safran SA; Alexander T; Boyden SE; Morgan ND; Shah AA; Mayes MD; Doumatey A; Bentley AR; Shriner D; Domsic RT; Medsger TA; Ramos PS; Silver RM; Steen VD; Varga J; Hsu V; Saketkoo LA; Schiopu E; Khanna D; Gordon JK; Kron B; Criswell LA; Gladue H; Derk CT; Bernstein EJ; Bridges SL; Shanmugam VK; Kolstad KD; Chung L; Kafaja S; Jan R; Trojanowski M; Goldberg A; Korman BD; Steinbach PJ; Chandrasekharappa SC; Mullikin JC; Adeyemo A; Rotimi C; Wigley FM; Kastner DL; Boin F; Remmers EF
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):552-562. PubMed ID: 31871193
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. The United Kingdom Systemic Sclerosis Study Group.
Maddison PJ; Stephens C; Briggs D; Welsh KI; Harvey G; Whyte J; McHugh N; Black CM
Medicine (Baltimore); 1993 Mar; 72(2):103-12. PubMed ID: 8479323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
